Parenteral versus oral iron therapy for adults and children with chronic kidney disease
| Field | Value | Language |
| dc.contributor.author | Webster, Angela C | |
| dc.contributor.author | Hodson, Elisabeth | |
| dc.date.accessioned | 2020-05-19 | |
| dc.date.available | 2020-05-19 | |
| dc.date.issued | 2012-01-01 | |
| dc.identifier.citation | Webster AC, Hodson EH. Parenteral versus oral iron therapy for adults and children with chronic kidney disease. Nephrology 2012, 17 (2012) 774–775. doi: 10.1111/j.1440-1797.2012.01660.x | en |
| dc.identifier.uri | https://hdl.handle.net/2123/22315 | |
| dc.description.abstract | What is this review about? The use of intravenous compared with oral iron supplements in patients with chronic kidney disease (CKD). | en |
| dc.language.iso | en | en |
| dc.publisher | Wiley | en |
| dc.rights | Other | en |
| dc.title | Parenteral versus oral iron therapy for adults and children with chronic kidney disease | en |
| dc.type | Article | en |
| dc.identifier.doi | 0.1111/j.1440-1797.2012.01660.x | |
| dc.type.pubtype | Post-print | en |
| dc.rights.other | This is the peer reviewed version of the following article: [Webster AC, Hodson EH. Parenteral versus oral iron therapy for adults and children with chronic kidney disease. Nephrology 2012, 17 (2012) 774–775. doi: 10.1111/j.1440-1797.2012.01660.x], which has been published in final form at [https://doi.org/10.1111/j.1440-1797.2012.01660.x]. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions. | en |
| usyd.faculty | Faculty of Medicine and Health, Sydney Medical School | en |
Associated file/s
Associated collections